Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists

The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patient...

Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Th...